Report Interpretation

Overview

This update examines the final two capital injections in China’s six-large-SOE-bank programme. Morgan Stanley considers ABC’s expected dilution broadly anticipated and ICBC’s dilution lower than both its own and market expectations, with the overall effect on existing shareholders expected to be limited.

Core views

ABC and ICBC announced Rmb160bn and Rmb100bn capital injections, respectively, completing the capital-injection programme for China’s six large SOE banks. The Ministry of Finance, China National Tobacco Corporation, and related subsidiaries will subscribe to the placements, and all proceeds are intended to replenish common equity tier 1 (CET1) capital. Pricing is market-oriented: both placements cannot be priced below the 20-trading-day average before the pricing date, while ABC’s price also cannot fall below its A-share price. Morgan Stanley estimates that ABC’s share issuance will dilute existing shareholders by approximately 6.6%, broadly in line with expectations. ICBC’s estimated dilution is 3.6%, lower than expected and viewed as manageable. The firm had expected dilution of around 5-6% for both banks after Rmb300bn of special government bonds for capital injection was announced in early 2026. Because part of those funds is being directed to other financial institutions, ICBC’s capital injection and resulting dilution are below Morgan Stanley’s and the market’s earlier expectations. The capital raises materially reinforce regulatory capital. ABC’s CET1 ratio is estimated to rise by 61 basis points to 11.41%, while ICBC’s is estimated to rise by 34 basis points to 13.55%. On the report’s assumptions, both placements are implemented on November 30, 2026. ABC’s shares outstanding would rise from 349,983 million to 372,972 million, while ICBC’s would rise from 356,406 million to 369,194 million. The related 2027E EPS reductions are estimated at 6.16% for ABC and 3.46% for ICBC. Morgan Stanley argues that the mechanical impact on dividends per share should be partly offset by operating improvement and payout policy. Both banks increased interim dividend payout ratios from 30% to 31%, and profit growth has rebounded. It also believes further capital needs at ABC and ICBC are relatively low because window guidance has eased, loan growth is becoming more rational, capital levels remain healthy, and profitability has improved. The report sees a stronger case for allocating some public capital toward insurers and policy financial institutions rather than directing additional capital to these two banks. In its view, insurers offer greater balance-sheet growth potential and could deploy injected capital into long-term capital that generates attractive return on equity. Additional support for policy financial institutions could help them meet policy responsibilities, reduce those burdens on SOE banks, and thereby support SOE-bank valuations.

Analysis framework

Morgan Stanley compares the announced issuance sizes and pricing conditions with its prior dilution expectations, then estimates pro forma share-count, EPS, book-value-per-share, and CET1 effects. It places the results in the context of prior government-bond funding, bank profitability and dividend policy, and evaluates the relative use of capital across SOE banks, insurers, and policy financial institutions.

Methodology notes

• Other

  Pro forma capital-injection and share-dilution analysis

  The report estimates how each placement changes shares outstanding, EPS, book value per share, and CET1 capital ratios after the planned injections.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Agricultural Bank of China

  Primary subject of the capital-injection analysis; planned Rmb160bn placement.

  Strengths

  CET1 ratio is estimated to rise 61bps to 11.41%; interim payout ratio increased to 31%; profit growth has rebounded.

  Weaknesses

  Estimated shareholder dilution of approximately 6.6% and 2027E EPS reduction of 6.16%.

  Comparison

  Dilution is broadly in line with Morgan Stanley’s prior expectation, unlike ICBC’s lower-than-expected dilution.

  Risks

  Mechanical dilution from the share placement.

• Industrial and Commercial Bank of China

  Primary subject of the capital-injection analysis; planned Rmb100bn placement.

  Strengths

  CET1 ratio is estimated to rise 34bps to 13.55%; interim payout ratio increased to 31%; dilution is considered manageable.

  Weaknesses

  Estimated 2027E EPS reduction of 3.46% from the placement.

  Comparison

  Estimated dilution of 3.6% is below Morgan Stanley’s and market expectations of roughly 5-6%.

  Risks

  Mechanical dilution from the share placement.

Key data

• ABC capital injectionRmb160bnPlacement proceeds are to replenish CET1 capital.
• ICBC capital injectionRmb100bnPlacement proceeds are to replenish CET1 capital.
• Estimated dilutionABC ~6.6%; ICBC 3.6%ABC is in line with expectations; ICBC is lower than expected.
• Post-injection CET1 ratioABC 11.41%; ICBC 13.55%Increases of 61bps and 34bps, respectively.
• 2027E EPS changeABC -6.16%; ICBC -3.46%Estimated pro forma impact of the placements.
• Interim dividend payout ratio31%Both banks increased the ratio from 30%.

Impact & implications

Morgan Stanley expects the capital injections to strengthen both banks’ CET1 positions without creating a severe surprise for existing shareholders. It sees ICBC’s smaller-than-expected dilution as particularly manageable and argues that allocating incremental capital to insurers and policy financial institutions may be more productive while also easing policy-related burdens on SOE banks.